This study aims to elucidate the role of DHT in modulating tumor cell susceptibility to immune-mediated cytotoxicity, particularly through the AR and NF-κB pathways, and to explore the potential implications for cancer treatment in EBVaGC. Here, NFKB1 is linked to cancer.